Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16

Enhanced safety surveillance (ESS) was conducted in the United Kingdom and Finland for Vaxigrip and Intanza 15 µg to comply with the European Medicines Agency interim guidance aimed to detect any potential increase in reactogenicity in near real time following the annual update of the influenza vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Bricout, Hélène, Chabanon, Anne Laure, Souverain, Audrey, Sadorge, Christine, Vesikari, Timo, Caroe, Timothy David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2017
Materias:
Surveillance and Outbreak Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434878/
https://www.ncbi.nlm.nih.gov/pubmed/28494843
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.18.30527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434878/
https://www.ncbi.nlm.nih.gov/pubmed/28494843
http://dx.doi.org/10.2807/1560-7917.ES.2017.22.18.30527

Ejemplares similares